- Full Year 2024 Eisai Co Ltd Earnings Presentation TranscriptMay 15, 2024
- Eisai Co Ltd Information Meeting TranscriptMar 08, 2024
- Q3 2024 Eisai Co Ltd Earnings Presentation TranscriptFeb 06, 2024
- Eisai Co Ltd Launch of LEQEMBI in Japan TranscriptDec 13, 2023
- Q2 2024 Eisai Co Ltd Earnings Presentation TranscriptNov 07, 2023
- Q1 2024 Eisai Co Ltd Earnings Presentation TranscriptAug 02, 2023
- Eisai Co Ltd Media and Investor Conference TranscriptJul 07, 2023
- Full Year 2023 Eisai Co Ltd Earnings Presentation TranscriptMay 15, 2023
- Eisai Co Ltd Information Meeting TranscriptMar 10, 2023
- Q3 2023 Eisai Co Ltd Earnings Call TranscriptFeb 06, 2023$61.5Earnings
- Eisai Co Ltd Approach to US Pricing for LEQEMBI Briefing TranscriptJan 07, 2023
- Eisai Co Ltd Clarity AD Study Briefing TranscriptNov 30, 2022
- Q2 2023 Eisai Co Ltd Earnings Call TranscriptNov 07, 2022$58.36Earnings
- Eisai Co Ltd Lecanemab Phase 3 Study Met Primary Endpoint Call TranscriptSep 28, 2022
- Q1 2023 Eisai Co Ltd Earnings Call TranscriptAug 05, 2022$46.1Earnings
- Full Year 2022 Eisai Co Ltd Earnings Presentation TranscriptMay 13, 2022
- Eisai Co Ltd Information Meeting TranscriptMar 16, 2022
- Q3 2022 Eisai Co Ltd Earnings Call TranscriptFeb 03, 2022$52.14Earnings
- Q2 2022 Eisai Co Ltd Earnings Call TranscriptNov 01, 2021$70.2Earnings
- Q1 2022 Eisai Co Ltd Earnings Call TranscriptAug 04, 2021$93.97Earnings
- Eisai Co Ltd FDA Grants Accelerated Approval for ADUHELM Presentation TranscriptJun 09, 2021
- Full Year 2021 Eisai Co Ltd Earnings Call TranscriptMay 12, 2021$71.51Earnings
- Eisai Co Ltd Information Meeting TranscriptMar 26, 2021
- Q3 2021 Eisai Co Ltd Earnings Call TranscriptFeb 03, 2021$71.88 (-2.86%)Earnings
- Q2 2021 Eisai Co Ltd Earnings Call TranscriptNov 05, 2020$74.75Earnings
- Q1 2021 Eisai Co Ltd Earnings Call TranscriptAug 03, 2020$80.01Earnings
- Full Year 2020 Eisai Co Ltd Earnings Call TranscriptMay 13, 2020$62 (-17.88%)Earnings
- Eisai Co Ltd Information Meeting TranscriptMar 06, 2020
- Q3 2020 Eisai Co Ltd Earnings Presentation and Conference Call TranscriptJan 31, 2020
- Full Year 2019 Eisai Co Ltd Earnings Presentation and Conference Call TranscriptMay 13, 2019
- Eisai Co Ltd Information Meeting TranscriptMar 08, 2019
Q2 2022 Eisai Co Ltd Earnings Call Transcript
[Interpreted] It is now time. We would like to begin financial results presentation session of Eisai Co., Ltd. for the second quarter fiscal 2021. This session is live streamed and distributed to those who are participating from telephone line. Those of you who are participating through the teleconference, please download the slides from our website and please click forward. Those of you who are watching live stream, please continue to watch the screen.
Now let me introduce the presenter today, Mr. Haruo Naito, Representative Corporate Officer and CEO. Now over to you, Mr. Naito, please.
[Interpreted] Thank you. This is Naito speaking. Now I would like to report to you the results recorded up until the end of the second quarter this fiscal year.
Now here, our overall P&L. As you see in the headline, Lenvima and other global brands, 4 in total, have steadily grown, and MORAb-202 and other strategic options have been made in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)